Skip to main content

H.R. 8205

Referred to Committee

ETHIC Act

Introduced 9/11/2020•116th Congress•House

Latest Action

Referred to the Subcommittee for Indigenous Peoples of the United States.

9/16/2020 • House

Summary

Ensuring Transparent Honest Information on COVID-19 Act or the ETHIC Act

This bill retroactively requires states and other jurisdictions to report specified COVID-19 (i.e., coronavirus disease 2019) data to the Centers for Disease Control and Prevention (CDC) as a condition of receiving certain COVID-19 funding. It also directs the CDC and others to take additional actions to address public health data systems, public health infrastructure, and health disparities.

Specifically, the bill directs the CDC to improve its data systems, develop relevant data and technology systems, and expand its public health infrastructure. The CDC must also award grants to government health departments to modernize their data systems, infrastructure, and collection of health disparities data.

Furthermore, the Department of Health and Human Services must commission a study from the National Academies of Sciences, Engineering, and Medicine on public health data infrastructure, and the Indian Health Service must, as advised by a panel of tribal representatives, conduct research on health inequities among tribal populations, including inequities related to COVID-19.

Introduced in House • 9/11/2020

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Blood and blood diseasesCardiovascular and respiratory healthChild healthComputers and information technologyCongressional oversightEmergency medical services and trauma careGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth care qualityHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHospital careIndian social and development programsInfectious and parasitic diseasesIntergovernmental relations

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (3)

Party Breakdown

3
Democrats
0
Republicans
0
Independents

Sponsor

R[
Rep. Castor, Kathy [D-FL-14]

Democrat • FL-14

Sponsored 9/11/2020

Cosponsors (2)

R[
Rep. Underwood, Lauren [D-IL-14]

D-IL-14

Joined 9/11/2020

R[
Rep. Haaland, Debra A. [D-NM-1]

D-NM-1

Joined 9/11/2020

Bill Journey

Originated in the House

Introduced

September 11, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Natural Resources, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House9/11/2020

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors2